Mohammad‐Reza Rafiyan

A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial

Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk et al. · Clinical Cancer Research · 2020 · 139 citations · Full text

Medicine, Immunology, Oncology +17

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program

Markus Moehler, Irina Gepfner‐Tuma, Annett Maderer et al. · BMC Cancer · 2016 · 66 citations · Full text

Medicine, Oncology, Pharmacology +14

Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma

Salah‐Eddin Al‐Batran, Mohammad‐Reza Rafiyan, Akin Atmaca et al. · Cancer Research · 2005 · 64 citations

Medicine, Oncology, Pathology +17

A phase 1/2a study to test the safety and immunogenicity of a p16^INK4a peptide vaccine in patients with advanced human papillomavirus‐associated cancers

Miriam Reuschenbach, Claudia Pauligk, Julia Karbach et al. · Cancer · 2016 · 49 citations · Full text

Medicine, Immunology, Oncology +15

Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

Stefan Kasper, Jens Kisro, Martin Fuchs et al. · BMC Cancer · 2018 · 13 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17